Relation between HbA and incident cardiovascular disease over a period of 6 years in the Hong Kong population.

AIM

The current trend on diabetes management advocates replacing the paradigm from a uniform to an individualized patient-centered haemoglobin A (HbA) target, but there is no consensus on the optimal HbA level. The study aimed at examining the association between HbA and the risk of cardiovascular diseases (CVD) for diabetic patients with different characteristics, in order to identify patient-centered treatment targets.

METHODS

A retrospective cohort study was conducted on 115,782 Chinese adult primary care patients with type 2 diabetes mellitus (DM) but no known CVD history, who were prescribed antidiabetic medications in 2010-2011. The cumulative mean HbA over a median follow-up period of 5.8 years was used to evaluate the relationship between HbA and CVD incidence using Cox analysis. Subgroup analyses were conducted by stratifying different baseline characteristics including gender, age, smoking status, diabetes duration, body mass index, Charlson's comorbidity index and DM treatment modalities.

RESULTS

For patients with a DM duration of<2years, an exponential relationship between HbA and risk of CVD was identified, suggesting that there was no threshold HbA level for CVD risk. For other diabetic patients, an HbA level of 6.8-7.2% was associated with a minimum risk for CVD and a J-shaped curvilinear association between HbA. The risk of CVD increased in patients with HbA<6.5% or ≥7.5%.

CONCLUSION

Among Chinese primary care patients at the early (<2years) disease stage, lower HbA targets (<6.5%) may be warranted to prevent CVD events whilst for all others, excessively lower HbA levels may not necessarily better and can potentially be harmful.